רווח תפעולי לפני פחת: retractable.com (RVP)

Retractable Technologies focuses on optimizing the production of proven injection systems, developing strategic partnerships with US government agencies to supply hospitals. Total EBITDA for the period reflects the daily cash result of core operations, where the current value is 0.00. The issuer's revenues are based on government tenders, compliance with sanitary regulations, and pricing competition within the medical equipment market.

This indicator captures actual cash inflows from core operations, allowing for the differentiation of natural seasonal fluctuations from systemic capital loss risks. By analyzing current operating profit in cash terms, the investor sees the result of purely organic growth for Retractable Technologies (RVP), which confirms the stability of a business model based on US government contracts without the use of risky merger and acquisition strategies.